Carregant...
Immunotoxicity Considerations for Next Generation Cancer Nanomedicines
Although interest and funding in nanotechnology for oncological applications is thriving, translating these novel therapeutics through the earliest stages of preclinical assessment remains challenging. Upon intravenous administration, nanomaterials interact with constituents of the blood inducing a...
Guardat en:
| Publicat a: | Adv Sci (Weinh) |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6774033/ https://ncbi.nlm.nih.gov/pubmed/31592123 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/advs.201900133 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|